Spots Global Cancer Trial Database for Expanded Access Neoantigen Vaccine in Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expanded Access Neoantigen Vaccine in Solid Tumors
Official Title: Expanded Access Neoantigen Vaccine in Solid Tumors
Study ID: NCT03914872
Conditions
Study Description
Brief Summary: This is an expanded access use study. Safety data will be collected from participants.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Washington University School of Medicine, Saint Louis, Missouri, United States
Contact Details
Name: William E Gillanders, M.D.
Affiliation: Washington University School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
